| Last Price | Today's Change | 52-Week Range | Trading Volume |
|---|---|---|---|
| 33.52 | 0.99 (+3.04%) | 20.04 - 37.40 | 524.8 thousand (Above Avg) |
Market data as of 3:59PM 06/19/13. Quotes are delayed by at least 15 min.
| Open | 32.63 |
|---|---|
| Previous Close | 32.53 |
| Day's Range | 32.63 - 33.85 |
| Market Cap | 1.9B |
| Avg Volume (10 Day) | 431.5K |
| Price/Earnings (Trailing 12 Mo.) | 55.1x |
| Earnings Per Share (Trailing 12 Mo.) | 0.59 |
| Dividend Yield | No Dividend |


These seven metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Performed well consistently? | Fail |
|---|---|
| Avoids excess debt? | Pass |
| Converting sales to profits? | Fail |
| Shareholder's money handled rationally? | Fail |
| Increased shareholder value? | Fail |
| Consistently increased owner earnings? | Fail |
| Sells at 25% discount to intrinsic value? | Neutral |


These eight metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Pays a cash dividend? | Fail |
|---|---|
| Room to increase dividends? | Fail |
| Increased earnings over time? | Pass |
| Borrows within reasonable limits? | Pass |
| Stock is undervalued? | Fail |
| Have investors caught on? | Fail |
| Has support of institutional investors? | Fail |
| Has sufficient liquidity? | Pass |
No news headlines available for MDCO
| MDCO | Industry Range | |
|---|---|---|
| Revenue Growth (1yr) | 17.73% | |
| Net Income Growth (1yr) | -71.23% | |
| Total Debt/Equity | 0.37 | |
| LT Debt/Equity | 0.37 | |
| Earnings Yield | 1.81% | |
| Price/Sales | 3.10 |
| Company | Last | Change |
|---|---|---|
| Taro Pharmaceutical Industries Ltd | 57.57 | -0.02% |
| Isis Pharmaceuticals Inc | 22.58 | -2.17% |
| Amarin Corporation PLC | 6.47 | -1.97% |
| Orexigen Therapeutics Inc | 6.33 | -0.78% |
| Simcere Pharmaceutical Group | 9.48 | 0.00% |
Data is delayed by at least 15 min.